发明名称 |
Risperidone-containing implants and methods of use thereof |
摘要 |
The present invention provides implants comprising a therapeutic drug and a polymer containing polylactic acid (PLA) and optionally polyglycolic acid (PGA). The present invention also provides methods of maintaining a therapeutic level of a drug in a subject, releasing a therapeutic drug at a substantially linear rate, and treating schizophrenia and other diseases and disorders, utilizing implants of the present invention. |
申请公布号 |
US9439905(B2) |
申请公布日期 |
2016.09.13 |
申请号 |
US201414286168 |
申请日期 |
2014.05.23 |
申请人 |
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
发明人 |
Siegel Steven;Winey Karen |
分类号 |
A61F2/02;A61K31/517;A61K9/16;A61L27/58;A61K9/00;A61K9/20;A61K31/192;A61K31/445;A61K31/519;A61K31/549;A61K31/573;A61K31/60;A61K31/451;A61K47/34;A61K9/70 |
主分类号 |
A61F2/02 |
代理机构 |
Pearl Cohen Zedek Latzer Baratz LLP |
代理人 |
Cohen Mark S.;Pearl Cohen Zedek Latzer Baratz LLP |
主权项 |
1. A method for treating schizophrenia in a subject in need thereof, the method comprising: administering to said subject a controlled release composition for providing an implant, said composition comprising a therapeutic drug and a polymer, said polymer comprising polylactic acid (PLA) and optionally polyglycolic acid (PGA) in a PLA:PGA molar ratio between 50:50 and 100:0, wherein said therapeutic drug is present in an amount of about 10%-60% of the mass of said composition, wherein the presence of said polymer in said composition extends the release duration of said therapeutic drug in a subject, and wherein said therapeutic drug is risperidone or 9-OH-risperidone, thereby treating said schizophrenia in said subject. |
地址 |
Philadelphia PA US |